Gurvich, A., M. Begemann, L. Dahm, D. Sargin, K. Miskowiak and H. Ehrenreich: A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. In: Bipolar Disorders 16, 8, 881-888 (2014).
Kästner, A., S. Grube, A. El-Kordi, B. Stepniak, H. Friedrichs, D. Sargin, J. Schwitulla, M. Begemann, I. Giegling, K. W. Miskowiak, S. Sperling, K. Hannke, A. Ramin, R. Heinrich, O. Gefeller, K.-A. Nave, D. Rujescu and H. Ehrenreich: Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. In: Molecular Medicine 18, 1029-1040 (2012).
Sargin, D., A. El-Kordi, A. Agarwal, M. Müller, S. M. Wojcik, I. Hassouna, S. Sperling, K.-A. Nave and H. Ehrenreich: Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. In: BMC Biology 9, Seq. No.: 27 (2011).
Sargin, D., H. Friedrichs, A. El-Kordi and H. Ehrenreich: Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. In: Best Practice and Research Clinical Anaesthesiology 24, 4, 573-594 (2010).
Sargin, D., I. Hassouna, S. Sperling, A.-L. Sirén and H. Ehrenreich: Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. In: GLIA 57, 7, 693-702 (2009).
Adamcio, B., D. Sargin, A. Stradomska, L. Medrihan, C. Gertler, F. Theis, M. Zhang, M. Müller, I. Hassouna, K. Hannke, S. Sperling, K. Radyushkin, A. El-Kordi, L. Schulze, A. Ronnenberg, F. Wolf, N. Brose, J.-S. Rhee, W. Zhang and H. Ehrenreich: Erythropoietin enhances hippocampal long-term potentiation and memory. In: BMC Biology 6, Seq. No.: 37 (2008).
doi: 10.1186/1741-7007-6-37
Begemann, M., D. Sargin, M. J. Rossner, C. Bartels, F. Theis, S. P. Wichert, N. Stender, B. Fischer, S. Sperling, S. Stawicki, A. Wiedl, P. Falkai, K.-A. Nave and H. Ehrenreich: Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. In: Molecular Medicine 14, 9-10, 546-552 (2008).
doi: 10.2119/2008-00053.Begemann
Ehrenreich, H., C. Bartels, D. Sargin, S. Stawicki and H. Krampe: Recombinant human erythropoietin in the treatment of human brain disease : focus on cognition. In: Journal of Renal Nutrition 18, 1, 146-153 (2008).
doi: 10.1053/j.jrn.2007.10.029
Sirén, A.-L., K. Radyushkin, S. Boretius, D. Kämmer, C.-C. Riechers, O. Natt, D. Sargin, T. Watanabe, S. Sperling, T. Michaelis, J. Price, B. Meyer, J. Frahm and H. Ehrenreich: Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. In: Brain 129, 480-489 (2006).
The Max Planck Society does not take any responsibility for the content of this export.